Regulation And Legal
iSERA Lifesciences Receives SEBI Warning Letter
iSERA Lifesciences received a SEBI warning letter for non-compliance with listing regulations.
The company failed to submit disclosures required under Regulations 7(3), 13(3), and 47.
The warning lett
